Ursolic acid induces cell death and modulates autophagy through JNK pathway in apoptosis-resistant colorectal cancer cells

Journal of Nutritional Biochemistry

Volumn 24, Issue 4, 2013, Pages 706-712

  Xavier, Cristina P R ^a   Lima, Cristovao F ^a   Pedro, Dalila F N ^a   Wilson, Jonathan M ^b   Kristiansen, Karsten ^c   Pereira Wilson, Cristina ^a,c  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

5 fluorouracil; Autophagy; Cell death; Colorectal carcinoma; JNK; Ursolic acid

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; PROTEIN P62; STRESS ACTIVATED PROTEIN KINASE; URSOLIC ACID;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; CELL DEATH; COLORECTAL CANCER; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENES, P53; HUMANS; IN SITU NICK-END LABELING; MAP KINASE KINASE 4; MICE; MUTATION; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 84875066821     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.04.004     Document Type: Article

References (44)

1. Bhushan S., McLeod H., Walko C.M. Role of pharmacogenetics as predictive biomarkers of response and/or toxicity in the treatment of colorectal cancer. Clin Colorectal Cancer 2009, 8:15-21.
2. De Dosso S., Sessa C., Saletti P. Adjuvant therapy for colon cancer: present and perspectives. Cancer Treat Rev 2009, 35:160-166.
3. Adamsen B.L., Kravik K.L., Clausen O.P., De Angelis P.M. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment. Int J Oncol 2007, 31:1491-1500.
4. Violette S., Poulain L., Dussaulx E., Pepin D., Faussat A.M., Chambaz J., et al. Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status. Int J Cancer 2002, 98:498-504.
5. Mader R.M., Muller M., Steger G.G. Resistance to 5-fluorouracil. Gen Pharmacol 1998, 31:661-666.
6. Mori S., Ogata Y., Shirouzu K. Biological features of sporadic colorectal carcinoma with high-frequency microsatellite instability: special reference to tumor proliferation and apoptosis. Int J Clin Oncol 2004, 9:322-329.
7. Jover R., Zapater P., Castells A., Llor X., Andreu M., Cubiella J., et al. Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 2006, 55:848-855.
8. Warusavitarne J., Schnitzler M. The role of chemotherapy in microsatellite unstable (MSI-H) colorectal cancer. Int J Colorectal Dis 2007, 22:739-748.
9. Degterev A., Yuan J. Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol 2008, 9:378-390.
10. Tan M.L., Ooi J.P., Ismail N., Moad A.I., Muhammad T.S. Programmed cell death pathways and current antitumor targets. Pharm Res 2009, 26:1547-1560.
11. Maiuri M.C., Zalckvar E., Kimchi A., Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007, 8:741-752.
12. Brech A., Ahlquist T., Lothe R.A., Stenmark H. Autophagy in tumour suppression and promotion. Mol Oncol 2009, 3:366-375.
13. Chen S., Rehman S.K., Zhang W., Wen A., Yao L., Zhang J. Autophagy is a therapeutic target in anticancer drug resistance. Biochim Biophys Acta 1806, 2010:220-229.
14. Kondo Y., Kanzawa T., Sawaya R., Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005, 5:726-734.
15. Liu J., Lin A. Role of JNK activation in apoptosis: a double-edged sword. Cell Res 2005, 15:36-42.
16. Wagner E.F., Nebreda A.R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 2009, 9:537-549.
17. Park K.J., Lee S.H., Lee C.H., Jang J.Y., Chung J., Kwon M.H., et al. Upregulation of Beclin-1 expression and phosphorylation of Bcl-2 and p53 are involved in the JNK-mediated autophagic cell death. Biochem Biophys Res Commun 2009, 382:726-729.
18. Lorin S., Borges A., Ribeiro Dos Santos L., Souquere S., Pierron G., Ryan K.M., et al. c-Jun NH2-terminal kinase activation is essential for DRAM-dependent induction of autophagy and apoptosis in 2-methoxyestradiol-treated Ewing sarcoma cells. Cancer Res 2009, 69:6924-6931.
19. Li D.D., Wang L.L., Deng R., Tang J., Shen Y., Guo J.F., et al. The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells. Oncogene 2009, 28:886-898.
20. Wong C.H., Iskandar K.B., Yadav S.K., Hirpara J.L., Loh T., Pervaiz S. Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROS-dependent ERK and JNK activation. PLoS One 2010, 5:e9996.
21. Cheng Y., Qiu F., Tashiro S., Onodera S., Ikejima T. ERK and JNK mediate TNFalpha-induced p53 activation in apoptotic and autophagic L929 cell death. Biochem Biophys Res Commun 2008, 376:483-488.
22. Lorin S., Pierron G., Ryan K.M., Codogno P., Djavaheri-Mergny M. Evidence for the interplay between JNK and p53-DRAM signalling pathways in the regulation of autophagy. Autophagy 2010, 6:153-154.
23. Rajamanickam S., Agarwal R. Natural products and colon cancer: current status and future prospects. Drug Dev Res 2008, 69:460-471.
24. Singletary K., Milner J. Diet, autophagy, and cancer: a review. Cancer Epidemiol Biomarkers Prev 2008, 17:1596-1610.
25. Ikeda Y., Murakami A., Ohigashi H. Ursolic acid: an anti- and pro-inflammatory triterpenoid. Mol Nutr Food Res 2008, 52:26-42.
26. Xavier C.P., Lima C.F., Preto A., Seruca R., Fernandes-Ferreira M., Pereira-Wilson C. Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells. Cancer Lett 2009, 281:162-170.
27. Namimatsu S., Ghazizadeh M., Sugisaki Y. Reversing the effects of formalin fixation with citraconic anhydride and heat: a universal antigen retrieval method. J Histochem Cytochem 2005, 53:3-11.
28. Xavier C.P., Lima C.F., Rohde M., Pereira-Wilson C. Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation. Cancer Chemother Pharmacol 2011, 68(6):1449-1457.
29. de Bruin E.C., Medema J.P. Apoptosis and non-apoptotic deaths in cancer development and treatment response. Cancer Treat Rev 2008, 34:737-749.
30. Landriscina M., Maddalena F., Laudiero G., Esposito F. Adaptation to oxidative stress, chemoresistance, and cell survival. Antioxid Redox Signal 2009, 11:2701-2716.
31. Xiao H., Zhang Q., Lin Y., Reddy B.S., Yang C.S. Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int J Cancer 2008, 122:2115-2124.
32. Yeh C.T., Wu C.H., Yen G.C. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase. Akt and mammalian target of rapamycin signaling. Mol Nutr Food Res 2010, 54:1285-1295.
33. Zhang Y.X., Kong C.Z., Wang L.H., Li J.Y., Liu X.K., Xu B., et al. Ursolic acid overcomes Bcl-2-mediated resistance to apoptosis in prostate cancer cells involving activation of JNK-induced Bcl-2 phosphorylation and degradation. J Cell Biochem 2010, 109:764-773.
34. Zhang Y., Kong C., Zeng Y., Wang L., Li Z., Wang H., et al. Ursolic acid induces PC-3 cell apoptosis via activation of JNK and inhibition of Akt pathways in vitro. Mol Carcinog 2010, 49:374-385.
35. Liu X.S., Jiang J. Induction of apoptosis and regulation of the MAPK pathway by ursolic acid in human leukemia K562 cells. Planta Med 2007, 73:1192-1194.
36. Zhang Y.X., Kong C.Z., Wang H.Q., Wang L.H., Xu C.L., Sun Y.H. Phosphorylation of Bcl-2 and activation of caspase-3 via the c-Jun N-terminal kinase pathway in ursolic acid-induced DU145 cells apoptosis. Biochimie 2009, 91:1173-1179.
37. Prasad S., Yadav V.R., Kannappan R., Aggarwal B.B. Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors: evidence for the role of reactive oxygen species and JNK. J Biol Chem 2011, 286:55-57.
38. Corcelle E.A., Puustinen P., Jaattela M. Apoptosis and autophagy: targeting autophagy signalling in cancer cells - 'trick or treats'?. FEBS J 2009, 276:6084-6096.
39. He C., Klionsky D.J. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009, 43:67-93.
40. Tasdemir E., Chiara Maiuri M., Morselli E., Criollo A., D'Amelio M., Djavaheri-Mergny M., et al. A dual role of p53 in the control of autophagy. Autophagy 2008, 4:810-814.
41. Morselli E., Tasdemir E., Maiuri M.C., Galluzzi L., Kepp O., Criollo A., et al. Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 2008, 7:3056-3061.
42. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326.
43. De Angel R.E., Smith S.M., Glickman R.D., Perkins S.N., Hursting S.D. Antitumor effects of ursolic acid in a mouse model of postmenopausal breast cancer. Nutr Cancer 2010, 62:1074-1086.
44. Shanmugam M.K., Manu K.A., Ong T.H., Ramachandran L., Surana R., Bist P., et al. Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model. Int J Cancer 2011, 129:1552-1563.